2013Chinese and Foreign Medical ResearchRequires access

The Clinical Efficacy of Acarbose with Metformin in the Treatment of Type 2 Diabetes

Li L

Open publisher page 1 citations

Abstract

Objective:To explore the clinical effect of acarbose and metformin in patients with type 2 diabetes.Methods:Admitted to our hospital from February 2010 to December 2011,98 cases of patients with type 2 diabetes were randomly divided into control group and the observation group,49 cases in each group.The control group were treated with metformin,the observation group was treated with the combination therapy of metformin and acarbose,patients received 12 weeks of treatment.The two groups of patients after treatment,fasting blood glucose,postprandial 2 h blood sugar for review,the two groups were compared treatment effects.Results:After treatment,blood glucose difference was statistically significant(P0.05).The control group and the observation group treatment efficiency of 81.64%,95.92%,and the observation group was significantly higher than that in the control group(P0.05).The two groups of patients during treatment no serious adverse reactions,the difference was not statistically significant(P0.05).Conclusion:The effect of acarbose with metformin for the treatment of patients with type 2 diabetes significantly,is safe and effective,it is worth the widespread promotion and use in clinical.

About this research paper

What this paper is about

Objective:To explore the clinical effect of acarbose and metformin in patients with type 2 diabetes.Methods:Admitted to our hospital from February 2010 to December 2011,98 cases of patients with type 2 diabetes were randomly divided into control group and the observation group,49 cases in each group.The control group were treated with metformin,the observation group was treated with the combination therapy of metformin and acarbose,patients received 12 weeks of treatment.The two groups of patients after treatment,fasting blood glucose,postprandial 2 h blood sugar for review,the two groups were compared treatment effects.Results:After treatment,blood glucose difference was statistically significant(P0.05).The control group and the observation group treatment efficiency of 81.64%,95.92%,and the observation group was significantly higher than that in the control group(P0.05).The two groups of patients during treatment no serious adverse reactions,the difference was not statistically significant(P0.05).Conclusion:The effect of acarbose with metformin for the treatment of patients with type 2 diabetes significantly,is safe and effective,it is worth the widespread promotion and use in clinical.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the clinical effect of acarbose and metformin in patients with type 2 diabetes.Methods:Admitted to our hospital from February 2010 to December 2011,98 cases of patients with type 2 diabetes were randomly divided into control group and the observation group,49 cases in each group.The control group were treated with metformin,the observation group was treated with the combination therapy of metformin and acarbose,patients received 12 weeks of treatment.The two groups of patients after treatment,fasting blood glucose,postprandial 2 h blood sugar for review,the two groups were compared treatment effects.Results:After treatment,blood glucose difference was statistically significant(P0.05).The control group and the observation group treatment efficiency of 81.64%,95.92%,and the observation group was significantly higher than that in the control group(P0.05).The two groups of patients during treatment no serious adverse reactions,the difference was not statistically significant(P0.05).Conclusion:The effect of acarbose with metformin for the treatment of patients with type 2 diabetes significantly,is safe and effective,it is worth the widespread promotion and use in clinical.

Key concepts: Acarbose, Medicine, Postprandial, Metformin, Type 2 diabetes, Blood sugar, Internal medicine, Treatment and control groups

Related papers

Back to paper searchBrowse research topicsOriginal source
The Clinical Efficacy of Acarbose with Metformin in the Treatment of Type 2 Diabetes — Research Paper | ScholarLens